Oct 21, 2026Lonza’s AI strategy shows early results | Sanofi starts construction on German insulin plant

Oct 20, 2026Sanofi wins Facility of the Year Award | Cell Therapies, S2N.Bio tech transfer

Oct 17, 2026Lonza says it is well-positioned for growth | Kindeva secures $226M DLA contract

Oct 16, 2026Lonza’s Vacaville upgrades progressing per plan | Recipharm expands high potency offering

Oct 15, 2026Minnesota CDMO quadruples capacity | Charles River, Magellan team on stem cells

Oct 14, 2026India’s pharma industry looks beyond US | UCB’s $2B Georgia campus takes shape

Oct 13, 2026CDMOs at CPHI Milan say outsourced demand is strong | GSK’s $800M PA expansion

Oct 10, 2026Manufacturers adapt amid myriad of pressures | Robotics biomanufacturing startup raises $75M

Oct 9, 2026Thermo Fisher boosts manufacturing capacity | Alvotech, Lotte ink long-term partnership

Oct 8, 2026GLP-1 demand challenges pharma manufacturers | Olon boosts ADC platform in France

Oct 7, 2026Lonza scales Visp site in ADC growth strategy | Hovione claims world’s first tableting line

Oct 6, 2026Bayer plans $2.2B Ohio pharma site | Sterling expands UK ADC capacity

Oct 3, 2026AI adoption is faster than data readiness | Lonza, Asimov partner on lentiviral vectors

Oct 2, 2026SK pharmteco to invest over $200M in US | Varda raises $251M to make drugs in space

Oct 1, 2026A case for continuous biomanufacturing | Genentech breaks ground on $750M expansion

Sep 30, 2026BioNTech to close three sites in Germany | Lifecore to be acquired for $663.7M

Sep 29, 2026China’s manufacturing of FDA-approved drugs on rise | Vetter boosts fill-finish capacity

Sep 26, 2026Lilly vs. Novo in oral GLP-1 race | WuXi Biologics passes another FDA GMP inspection

Sep 25, 2026Data hurdles remain in AI-based pharma manufacturing | Altruist Biologics gets EMA GMP certification

Sep 24, 2026CDMOs invest in European API capabilities | WuXi XDC’s Singapore site marks GMP release

Sep 23, 2026Novo says manufacturing network ready for demand | Lilly breaks ground on $6.5B API facility

Sep 22, 2026Canada’s largest biomanufacturing investment | Resilience sells PA cell therapy site

Sep 19, 2026AI, bioreactors improve enzyme production | Cellares teams with cell therapy developer

Sep 18, 2026Cellares plots strategy post-BMS partnership | Neuland expands peptide capacity

Sep 17, 2026Thermo Fisher benefits from US reshoring | Hovione doubles US spray drying capacity

Latest Edition